MINNEAPOLIS, Aug. 4, 2017 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the ARK Care® Advance real-time diabetes management system and the ARK Care® Vita mobile app. Both systems are designed to help people with diabetes, and the healthcare professionals that care for them, have real-time access to blood glucose readings using an easy-to-use tool for monitoring and managing the disease.
Built on the foundation of simple logbooks and glucose tracking, ARK Care Advance translates that information into graphs and charts to easily identify, isolate and record changes within diabetes management. The ARK Care Vita app allows tracking of glucose readings, diet and exercise anywhere. The app will be available for download for both iOS and Android devices at the end of September.
Both ARK Care Advance and ARK Care Vita will be demonstrated at ARKRAY's booth at the American Association of Diabetes Educators annual meeting, which takes place today through August 7th in Indianapolis, IN.
"The launch of ARK Care Advance and ARK Care Vita represents the ARKRAY commitment to contributing to the health and well-being of people living with diabetes," said ARKRAY President Jonathan Chapman. "While many companies in the diabetes marketplace are reducing their investments in research and development, ARKRAY continues to deliver new products and services to help people with diabetes live a healthier and more active life."
Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to as juvenile diabetes). The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of Americans 65 years of age or greater will have diabetes.
About ARKRAY USA, Inc.
ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.
SOURCE ARKRAY USA, Inc.